Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
Uwe ReuterJohn H KregeLouise LombardElisa Gomez ValderasJudith Krikke-WorkelGrazia Dell-AgnelloSherie A DowsettDawn C BusePublished in: Cephalalgia : an international journal of headache (2021)
Lasmiditan was efficacious across multiple clinically relevant endpoints in the acute treatment of migraine independent of prior response to triptans.Trial Registration: CENTURION (NCT03670810); SAMURAI (NCT02439320); SPARTAN (NCT02605174).